sb 203580 has been researched along with Acute Symptom Flare in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen-Yu Hsu, A; Guan, X; Guo, Y; Pang, Z; Ran, N; Wang, F; Wang, G; Wang, Z; Yuan, Y; Zheng, R | 1 |
1 other study(ies) available for sb 203580 and Acute Symptom Flare
| Article | Year |
|---|---|
Combined treatment with SB203580 and dexamethasone suppresses non-typeable Haemophilus influenzae-induced Th17 inflammation response in murine allergic asthma.
Topics: Animals; Asthma; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Female; Haemophilus influenzae; Humans; Imidazoles; Inflammation; Lung; Mice; Mucin 5AC; Mucin-5B; Neutrophils; Ovalbumin; p38 Mitogen-Activated Protein Kinases; Pyridines; Respiratory Mucosa; Signal Transduction; Symptom Flare Up; Th17 Cells | 2019 |